Pituitary
Scope & Guideline
Empowering Researchers with Cutting-Edge Insights
Introduction
Aims and Scopes
- Clinical Management of Pituitary Disorders:
The journal emphasizes research on the clinical management of various pituitary disorders including acromegaly, Cushing's syndrome, and prolactinomas, exploring treatment efficacy and safety. - Endocrine and Metabolic Research:
A significant focus is placed on the endocrine implications of pituitary dysfunction, including hormonal therapies and their metabolic effects, with studies often examining the interaction between hormonal levels and systemic health. - Surgical Techniques and Outcomes:
Research on innovative surgical techniques, particularly endoscopic approaches for pituitary tumors, and their outcomes is a core area, aiming to improve patient safety and surgical success rates. - Pathophysiology and Molecular Mechanisms:
The journal includes studies that investigate the underlying pathophysiological mechanisms of pituitary tumors and related disorders, contributing to a better understanding of these complex conditions. - Patient-Centered Outcomes and Quality of Life:
There is a consistent focus on patient-reported outcomes and quality of life assessments, highlighting the psychosocial impact of pituitary disorders and treatments.
Trending and Emerging
- Impact of COVID-19 on Pituitary Disorders:
Recent publications have increasingly addressed the implications of COVID-19 on patients with pituitary disorders, exploring both the direct and indirect effects of the pandemic on management and outcomes. - Integration of Artificial Intelligence in Clinical Practice:
There is a growing interest in the application of artificial intelligence and machine learning models in predicting outcomes and aiding in the clinical decision-making process for pituitary disorders. - Long-term Outcomes of Hormonal Therapies:
Emerging research is focusing on the long-term effects and outcomes of hormonal therapies, particularly in relation to acromegaly and Cushing's syndrome, reflecting a trend towards understanding the chronic implications of these treatments. - Patient-Centered Research and Quality of Life:
A notable increase in studies assessing patient-reported outcomes and quality of life following treatment for pituitary disorders indicates a shift towards more holistic approaches in managing these conditions. - Research on Comorbidities Associated with Pituitary Disorders:
There is an increasing trend in exploring the comorbid conditions associated with pituitary disorders, particularly metabolic and cardiovascular risks, emphasizing the need for comprehensive management strategies.
Declining or Waning
- Historical Perspectives on Pituitary Disorders:
Research that focuses on historical or retrospective analyses of pituitary disorders or treatments has seen a decline, as the field shifts towards more contemporary studies with immediate clinical relevance. - Basic Science and Animal Models:
There is a noticeable decrease in studies involving basic science and animal models of pituitary disorders, as clinical applications and human studies gain more traction. - Epidemiological Studies on Rare Pituitary Tumors:
The frequency of epidemiological studies specifically targeting rare pituitary tumors has diminished, possibly due to the challenges in gathering sufficient data on these less common conditions. - General Reviews on Common Pituitary Disorders:
While systematic reviews remain important, there is less emphasis on general reviews of well-established pituitary disorders, as the focus shifts to more specific and novel research findings.
Similar Journals
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Transforming Insights into Solutions for ChildrenThe JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.
Journal of Endocrinology and Metabolism
Elevating the understanding of metabolic processes and endocrine functions.Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.
Archives of Endocrinology Metabolism
Fostering innovation in endocrinology research.Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Illuminating the Complexities of Hormonal InteractionsJOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.
CLINICAL ENDOCRINOLOGY
Elevating clinical practice through cutting-edge research.CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.
ENDOCRINE RESEARCH
Advancing the frontiers of hormonal science.ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.
ANNALES D ENDOCRINOLOGIE
Advancing Endocrinology: Bridging Research and Clinical PracticeANNALES D ENDOCRINOLOGIE is a prestigious academic journal dedicated to the vibrant field of endocrinology, encompassing key aspects of diabetes and metabolism. Published by MASSON EDITEUR, this journal has been a vital resource for researchers and healthcare professionals since its inception in 1946. With its impressive Q2 ranking in the Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) categories, it showcases a wealth of high-quality research, reviews, and contributions that push the boundaries of endocrinological science. Although not open access, the journal maintains a significant impact on the academic community, with ongoing discussion and dissemination of pivotal advancements. The comprehensive coverage from 1946 to 2024 ensures that a broad spectrum of hormonal disorders, therapeutic innovations, and metabolic health issues are thoroughly explored, reflecting its commitment to enhancing knowledge and clinical practice in endocrinology. By engaging with this journal, researchers, clinicians, and students alike can stay informed of the latest trends and discoveries within the endocrine field.
BMC Endocrine Disorders
Connecting researchers to enhance endocrine health outcomes.BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.
ENDOCRINE PATHOLOGY
Exploring the Complexities of Endocrine HealthENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.
Frontiers in Endocrinology
Advancing Knowledge in Endocrinology and MetabolismFrontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.